Study requirements for investigating HLA-associated progression of HIV disease, and review.
Gore
S M
SM
MRC Biostatistics Unit, Cambridge, UK.
Hutchinson
S J
SJ
Brettle
R P
RP
D003625:Data Collection; D016208:Databases, Factual; D018450:Disease Progression; D019317:Evidence-Based Medicine; D015658:HIV Infections / Q000276:immunology*; D006680:HLA Antigens; D015788:HLA-A1 Antigen; D015796:HLA-B27 Antigen; D015797:HLA-B35 Antigen; D015795:HLA-B8 Antigen; D015803:HLA-DR3 Antigen; D006801:Humans; D010641:Phenotype; D012307:Risk Factors
D006680:HLA Antigens; D015788:HLA-A1 Antigen; D015796:HLA-B27 Antigen; D015797:HLA-B35 Antigen; D015795:HLA-B8 Antigen; D015803:HLA-DR3 Antigen